These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 25498839)

  • 1. Unusual cause of aborted sudden cardiac death in a teen athlete: homozygosity for the 4G allele of the plasminogen activase inhibitor type 1 gene.
    Phillips SB; Batlivala S; Knudson JD
    Cardiol Young; 2015 Oct; 25(7):1428-30. PubMed ID: 25498839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of sudden cardiac death in children and young athletes.
    Sarquella-Brugada G; Campuzano O; Iglesias A; Sánchez-Malagón J; Guerra-Balic M; Brugada J; Brugada R
    Cardiol Young; 2013 Apr; 23(2):159-73. PubMed ID: 22824130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia.
    Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H
    J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G/5G promoter polymorphism in the PAI-1 gene.
    Väisänen SB; Humphries SE; Luong LA; Penttilä I; Bouchard C; Rauramaa R
    Thromb Haemost; 1999 Sep; 82(3):1117-20. PubMed ID: 10494774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
    Zöller B; García de Frutos P; Dahlbäck B
    Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
    Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
    Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S; Green FR; Scarabin PY; Nicaud V; Bara L; Dawson SJ; Humphries SE; Evans A; Luc G; Cambou JP
    Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogeneses of sudden cardiac death in national collegiate athletic association athletes.
    Harmon KG; Drezner JA; Maleszewski JJ; Lopez-Anderson M; Owens D; Prutkin JM; Asif IM; Klossner D; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):198-204. PubMed ID: 24585715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
    Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
    Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels.
    Sakata T; Kario K
    Atherosclerosis; 2011 Feb; 214(2):490-1. PubMed ID: 21122850
    [No Abstract]   [Full Text] [Related]  

  • 16. Sudden cardiac death in athletes.
    Link MS; Mark Estes NA
    Prog Cardiovasc Dis; 2008; 51(1):44-57. PubMed ID: 18634917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulant, antiplatelet agents].
    Ishikawa K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
    Brogren H; Wallmark K; Jern S; Karlsson L
    Thromb Res; 2008; 121(6):793-7. PubMed ID: 17884148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of sudden cardiac death: return to sport considerations in athletes with identified cardiovascular abnormalities.
    Link MS
    Br J Sports Med; 2009 Sep; 43(9):685-9. PubMed ID: 19734503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.